Hepatocyte odd protein shuttling (HOPS) is a bridging protein in the nucleophosmin-p19Arf network

被引:23
作者
Castelli, M. [1 ]
Pieroni, S. [1 ]
Brunacci, C. [1 ]
Piobbico, D. [1 ]
Bartoli, D. [1 ]
Bellet, M. M. [1 ]
Colombo, E. [2 ]
Pelicci, P. G. [2 ]
Della Fazia, M. A. [1 ]
Servillo, G. [1 ]
机构
[1] Univ Perugia, Dept Clin & Expt Med, I-06124 Perugia, Italy
[2] Inst Europeo Oncol, Dept Expt Oncol, Milan, Italy
关键词
nucleophosmin (NPM); p19(Arf); hepatocyte odd protein shuttling (HOPS); Tmub1; tumor suppressor gene; ACUTE MYELOID-LEUKEMIA; ARF TUMOR-SUPPRESSOR; ACUTE MYELOGENOUS LEUKEMIA; CYTOPLASMIC NUCLEOPHOSMIN; NORMAL KARYOTYPE; NPMC(+) AML; STABILITY; B23; TUMORIGENESIS; MUTATIONS;
D O I
10.1038/onc.2012.353
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nucleophosmin (NPM), a ubiquitously and abundantly expressed protein, occurs in the nucleolus, shuttling between the nucleoplasm and cytoplasm. The NPM gene is mutated in almost 30% of human acute myeloid leukemia cells. NPM interacts with p53 and p19(Arf), directs localization of p19(Arf) in the nucleolus and protects the latter from degradation. Hepatocyte odd protein shuttling (HOPS) is also a ubiquitously expressed protein that moves between the nucleus and cytoplasm. Within the nucleus of resting cells, HOPS overexpression causes cell cycle arrest in G0/G1. HOPS knockdown causes centrosome hyperamplification leading to multinucleated cells and the formation of micronuclei. We demonstrate a direct interaction of HOPS with NPM and p19(Arf), resulting in a functionally active trimeric complex. NPM appeared to regulate HOPS half-life, which, in turn, stabilized p19(Arf) and controlled its localization in the nucleolus. These findings suggest that HOPS acts as a functional bridge in the interaction between NPM and p19(Arf), providing new mechanistic insight into how NPM and p19(Arf) will oppose tumor cell proliferation.
引用
收藏
页码:3350 / 3358
页数:9
相关论文
共 38 条
[1]   Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance [J].
Alcalay, M ;
Tiacci, E ;
Bergomas, R ;
Bigerna, B ;
Venturini, E ;
Minardi, SP ;
Meani, N ;
Diverio, D ;
Bernard, L ;
Tizzoni, L ;
Volorio, S ;
Luzi, L ;
Colombo, E ;
Lo Coco, F ;
Mecucci, C ;
Falini, B ;
Pelicci, PG .
BLOOD, 2005, 106 (03) :899-902
[2]   DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis [J].
Bartkova, J ;
Horejsi, Z ;
Koed, K ;
Krämer, A ;
Tort, F ;
Zieger, K ;
Guldberg, P ;
Sehested, M ;
Nesland, JM ;
Lukas, C ;
Orntoft, T ;
Lukas, J ;
Bartek, J .
NATURE, 2005, 434 (7035) :864-870
[3]   Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23 [J].
Bertwistle, D ;
Sugimoto, M ;
Sherr, CJ .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (03) :985-996
[4]   MAJOR NUCLEOLAR PROTEINS SHUTTLE BETWEEN NUCLEUS AND CYTOPLASM [J].
BORER, RA ;
LEHNER, CF ;
EPPENBERGER, HM ;
NIGG, EA .
CELL, 1989, 56 (03) :379-390
[5]   The frequency of NPM1 mutations in childhood acute myeloid leukemia [J].
Braoudaki, Maria ;
Papathanassiou, Chrissa ;
Katsibardi, Katerina ;
Tourkadoni, Natalia ;
Karamolegou, Kalliopi ;
Tzortzatou-Stathopoulou, Fotini .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2010, 3
[6]   Identification and characterization of a novel peptide interacting with cAMP-responsive elements binding and cAMP-responsive elements modulator in mouse liver [J].
Brunacci, Cinzia ;
Piobbico, Danilo ;
Bartoli, Daniela ;
Castelli, Marilena ;
Pieroni, Stefania ;
Bellet, Marina Maria ;
Viola-Magni, Mariapia ;
Della Fazia, Maria Agnese ;
Servillo, Giuseppe .
LIVER INTERNATIONAL, 2010, 30 (03) :388-395
[7]   Aging and cancer cell biology, 2007 [J].
Campisi, Judith .
AGING CELL, 2007, 6 (03) :261-263
[8]   Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype [J].
Cazzaniga, G ;
Dell'Oro, MG ;
Mecucci, C ;
Giarin, E ;
Masetti, R ;
Rossi, V ;
Locatelli, F ;
Martelli, MF ;
Basso, G ;
Pession, A ;
Biondi, A ;
Falini, B .
BLOOD, 2005, 106 (04) :1419-1422
[9]   Nucleophosmin mutations in De novo acute myeloid leukemia:: The age-dependent incidences and the stability during disease [J].
Chou, WC ;
Tang, JL ;
Lin, LI ;
Yao, M ;
Tsay, W ;
Chen, CY ;
Wu, SJ ;
Huang, CF ;
Chiou, RJ ;
Tseng, MH ;
Lin, DT ;
Lin, KH ;
Chen, YC ;
Tien, HF .
CANCER RESEARCH, 2006, 66 (06) :3310-3316
[10]   Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant [J].
Colombo, E ;
Martinelli, P ;
Zamponi, R ;
Shing, DC ;
Bonetti, P ;
Luzi, L ;
Volorio, S ;
Bernard, L ;
Pruneri, G ;
Alcalay, M ;
Pelicci, PG .
CANCER RESEARCH, 2006, 66 (06) :3044-3050